Filana Therapeutics, Inc. (FLNA) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.0x

Market Cap

$39.62M

MomentumView details →

1D Return

−0.99%

YTD Return

—

RSI (14)

32.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.0x

Market Cap

$39.62M

RSI (14)

32.2

MomentumView details →

1D Return

−0.99%

YTD Return

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−66.47%

ROA (TTM)

−40.69%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$0.18

EPS Surprise

20.00%

Beats (12Q)

1/12

Next Q EPS Est

−$0.25

Avg Surprise (4Q)

20.00%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

2.08x

Quick Ratio

2.08x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−42.28M

Op. CF (TTM)

—

Next earningsOct 29, 2026 →

Latest newsMore news →

No recent news for FLNA.

Similar companies

Quantum-Si incorporatedQSIAW Mereo BioPharma Group plcMREO Lite Strategy, Inc.LITS Aligos Therapeutics, Inc.ALGS CervoMed Inc.CRVO Karyopharm Therapeutics Inc.KPTI Find similar companies →

Latest newsMore news →

No recent news for FLNA.